Navigation Links
Free Drug Samples Hike Out-of-Pocket Costs
Date:3/24/2008

Patients who get the samples spend more on prescription drugs, study says

MONDAY, March 24 (HealthDay News) -- Patients who receive free drug samples from their doctors end up having significantly higher out-of-pocket costs for their prescription drugs than people who don't receive free samples, a new study finds.

In fact, patients who received free samples spent about $166 in out-of-pocket costs on prescription drugs in the six months before receiving the samples, $244 for the six months in which they received samples, and $212 for the six months following receipt of the free drugs, the study found.

But patients who didn't get free samples spent about $178 on prescription drugs over six months.

"This is a curious finding because one would think, intuitively, that if you receive a free sample, one's out-of-pocket prescription cost would be lower, not higher," said lead researcher Dr. G. Caleb Alexander, an assistant professor of medicine at the University of Chicago Medical Center.

There are several possible explanations for the finding, Alexander said. One is that patients who receive free samples may be sicker than patients who don't get samples.

"The second possibility is that patients who receive free samples may go on to receive and fill prescriptions for the very same medicine that were initially begun as free samples," Alexander said. "We know that drugs that are available as free samples are those that are being widely marketed and promoted and these drugs are more expensive than their older, less promoted counterparts."

The study findings are published in the March 24 issue of the journal Medical Care.

For the study, Alexander's team collected data on 5,709 patients who had participated in the Medical Expenditure Panel Survey. The survey was done by the U.S. Agency for Healthcare Research and Quality and the patients were followed for up to two years.

Seventy-six percent of the patients had private health insurance. During the study period, 14 percent of them were given at least one drug sample. A total of 2,343 samples were distributed during the period, the researchers found.

Patients who received free samples were more likely to be younger and have private insurance, while patients with Medicaid were less likely to receive samples, the researchers noted.

The findings follow earlier research, reported in the February issue of the American Journal of Public Health, in which Harvard University researchers showed that more than 80 percent of free drug samples were given to wealthy and insured patients, not to uninsured and poorer patients.

Alexander said there are many ways doctors and patients can work together to reduce drug costs, but giving away free samples may not be the best one.

"Doctors and patients both should be encouraged to consider alternative ways to reduce patients' out-of-pocket costs," he said. "There are many other strategies doctors can use, such as prescribing a three-month rather than a one-month supply, such as using greater numbers of generic medicines, and discontinuing non-essential medicines."

Dr. David Katz, director of the Yale University School of Medicine's Prevention Research Center, said free samples aren't designed to help lower drug costs, but rather to sell newer and more expensive drugs.

"Almost every clinician's office is stocked with drug samples," he said. "For patients and providers alike, these free drugs can take on the aura of Halloween goodies. Passing them out feels like giving a gift."

But, Katz added, "free samples are by no means a long-term solution to high prescription drug costs. Rather, they are at least, in part, a marketing device, a chance to sample the wares."

The pharmaceutical industry had this to say: "Free pharmaceutical samples are beneficial to patients of all income levels. Patients are able to try out a new therapy - gaining valuable first-hand experience of its benefits and side effects - without making a co-payment," said Pharmaceutical Research and Manufacturers of America (PhRMA) senior vice president Ken Johnson.

"What's more, contrary to statements made by critics, America's physicians prescribe medicines based on a wide range of factors, not simply receipt of free prescription drug samples," Johnson added in a prepared statement.

More information

For more on prescription drug trends, visit the Kaiser Family Foundation.



SOURCES: G. Caleb Alexander, M.D., assistant professor of medicine, University of Chicago Medical Center; David Katz, M.D., M.P.H., director, Prevention Research Center, Yale University School of Medicine, New Haven, Conn.; March 21, 2008, prepared statement, Ken Johnson, senior vice president, Pharmaceutical Research and Manufacturers of America, Washington, D.c., March 24, 2008, Medical Care


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Most Free Drug Samples Go to Wealthy and Insured
2. Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples
3. Scientists using laser light to detect potential diseases via breath samples, says new study
4. Free drug samples may burden patients pockets
5. HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs
6. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
7. Over 500,000 Health Care Providers Now Cutting Costs, Saving Time Through CAQH Administrative Simplification Initiative
8. HSA Plans Gain Popularity as Premium Costs Rise
9. Obesity Driving Rising U.S. Health Costs
10. ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs
11. HR Under the Microscope: Metrics to Drive Costs Down Across HR Functions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
(Date:2/26/2017)... Philadelphia, PA (PRWEB) , ... February 26, 2017 , ... ... products and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for ... , Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age is ... University predict that 47 percent of all jobs in the United States may be ... “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing to ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... and Markets has announced the addition of the "Hemophilia Drugs Price ... ... Analysis and Strategies - 2016, provides drug pricing data and benchmarks in ... What are the key drugs marketed for Hemophilia ... market? What are the unit prices and annual treatment ...
(Date:2/24/2017)... 24, 2017 Medical information groups within ... their self-service capabilities to manage inquiries from external ... New research from consulting leader Best Practices, ... self-service website portals where HCPs can sign on ... of many findings to emerge from the new ...
Breaking Medicine Technology: